Leamon CP - Search Results

1

In vivo structural activity and optimization studies of folate-tubulysin conjugates.

Reddy JA, Dorton R, Dawson A, Vetzel M, Parker N, Nicoson JS, Westrick E, Klein PJ, Wang Y, Vlahov IR, Leamon CP. Reddy JA, et al. Among authors: leamon cp. Mol Pharm. 2009 Sep-Oct;6(5):1518-25. doi: 10.1021/mp900086w. Mol Pharm. 2009. PMID: 19630399

2

Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.

Leamon CP, Parker MA, Vlahov IR, Xu LC, Reddy JA, Vetzel M, Douglas N. Leamon CP, et al. Bioconjug Chem. 2002 Nov-Dec;13(6):1200-10. doi: 10.1021/bc0200430. Bioconjug Chem. 2002. PMID: 12440854

3

Folate-targeted chemotherapy.

Leamon CP, Reddy JA. Leamon CP, et al. Adv Drug Deliv Rev. 2004 Apr 29;56(8):1127-41. doi: 10.1016/j.addr.2004.01.008. Adv Drug Deliv Rev. 2004. PMID: 15094211 Review.

4

Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.

Reddy JA, Xu LC, Parker N, Vetzel M, Leamon CP. Reddy JA, et al. Among authors: leamon cp. J Nucl Med. 2004 May;45(5):857-66. J Nucl Med. 2004. PMID: 15136637 Free article.

5

Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.

Paulos CM, Reddy JA, Leamon CP, Turk MJ, Low PS. Paulos CM, et al. Among authors: leamon cp. Mol Pharmacol. 2004 Dec;66(6):1406-14. doi: 10.1124/mol.104.003723. Epub 2004 Sep 15. Mol Pharmacol. 2004. PMID: 15371560

6

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. Parker N, et al. Among authors: leamon cp. Anal Biochem. 2005 Mar 15;338(2):284-93. doi: 10.1016/j.ab.2004.12.026. Anal Biochem. 2005. PMID: 15745749

7

Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic.

Leamon CP, Reddy JA, Vlahov IR, Vetzel M, Parker N, Nicoson JS, Xu LC, Westrick E. Leamon CP, et al. Bioconjug Chem. 2005 Jul-Aug;16(4):803-11. doi: 10.1021/bc049709b. Bioconjug Chem. 2005. PMID: 16029021

8

Folate receptor specific anti-tumor activity of folate-mitomycin conjugates.

Reddy JA, Westrick E, Vlahov I, Howard SJ, Santhapuram HK, Leamon CP. Reddy JA, et al. Among authors: leamon cp. Cancer Chemother Pharmacol. 2006 Aug;58(2):229-36. doi: 10.1007/s00280-005-0151-z. Epub 2005 Dec 6. Cancer Chemother Pharmacol. 2006. PMID: 16331500

9

Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugate.

Leamon CP, Reddy JA, Vlahov IR, Kleindl PJ, Vetzel M, Westrick E. Leamon CP, et al. Bioconjug Chem. 2006 Sep-Oct;17(5):1226-32. doi: 10.1021/bc060145g. Bioconjug Chem. 2006. PMID: 16984132

10

Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice.

Lu Y, Xu LC, Parker N, Westrick E, Reddy JA, Vetzel M, Low PS, Leamon CP. Lu Y, et al. Among authors: leamon cp. Mol Cancer Ther. 2006 Dec;5(12):3258-67. doi: 10.1158/1535-7163.MCT-06-0439. Mol Cancer Ther. 2006. PMID: 17172429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters